TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
GHN Pharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 280 | 5,963 | 85 |
Financial expenses | 2,304 | 308 | 2,881 |
Earnings before taxes | -2,814 | 14,991 | 2,827 |
EBITDA | -1,905 | -1,510 | -1,480 |
Total assets | 85,718 | 92,202 | 83,672 |
Current assets | 2,273 | 3,302 | 4,002 |
Current liabilities | 199 | 333 | 543 |
Equity capital | 85,519 | 91,870 | 83,129 |
- share capital | 390 | 402 | 432 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 99.8% | 99.6% | 99.4% |
Turnover per employee | 140 | 2,982 | 42 |
Profit as a percentage of turnover | -1005.0% | 251.4% | 3325.9% |
Return on assets (ROA) | -0.6% | 16.6% | 6.8% |
Current ratio | 1142.2% | 991.6% | 737.0% |
Return on equity (ROE) | -3.3% | 16.3% | 3.4% |
Change turnover | -5,503 | 5,884 | -795 |
Change turnover % | -95% | 7448% | -90% |
Chg. No. of employees | 0 | 0 | 1 |
Chg. No. of employees % | 0% | 0% | 100% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.